Safety of botanical dietary supplements

Functional Foods: Biochemical and Processing Aspects

Volumn 2, Issue , 2016, Pages 367-393

  Betz, Joseph M ^a   Garland, Tam ^b   Page, Samuel W ^c  

^a American Herbal Products Association   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTANICAL DIETARY SUPPLEMENTS;

DIETARY SUPPLEMENTS;

EID: 84939562315     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (221)

1. Alderman, S., Kailas, S., Goldfarb, S., Singaram, C. and Malone, D.G. (1994) Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J. Clin. Gastroenterol. 19, 242-247.
2. Almeida, J.C. and Grimsley, E.W. (1996) Coma from the health food store. Ann. Intern. Med. 125, 940.
3. Ameer, M. and Weintraub, R.A. (1997) Drug interactions with grapefruit juice. Clin Pharmacokinet. 33, 103-121.
4. American Herbal Products Association (1992) Foster, S. (ed.), Herbs of Commerce, American Herbal Products Association, Austin, TX.
5. Anderson, I.B., Mullen, W.H., Meeker, J.E., Khojasteh-Bakht, S.C., Oishi, S., Nelson, S.D. and Blanc, P.D. (1996) Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern. Med. 124, 726-734.
6. Anpalahan, M. and Le Couteur, D.G. (1998) Deliberate self-poisoning with eucalyptus oil in an elderly woman. Aust. N. Z. J. Med. 28, 58.
7. Asatoor, A.M., Levi, A.J. and Milne, M.D. (1963) Tranylcypromine and cheese. Lancet. 2, 733
8. Astrup, A.V., Breum, L. and Toubro, S. (1995) Pharmacological and clinical studies of ephedrine and other thermogenic agonists. Obes. Res. 3, 537S-540S.
9. Awang, D.V.C. (1991) Maternal use of ginseng and neonatal androgenization. JAMA. 265, 1839.
10. Awang, D.V.C. (1996) Siberian ginseng toxicity may be case of mistaken identity. Can. Med. Assoc. J. 155, 1237.
11. Bach, N., Thung, S.N. and Schaffner, F. (1989) Comfrey herb tea-induced hepatic venoocclusive disease. Am. J. Med. 87, 97-99.
12. Bailey, D.G., Spence, J.D., Edgar, B., Bayliff, C.D. and Arnold, J.M.O. (1989) Ethanol enhances the hemodynamic effects of felodipine. Clin. Invest. Med. 12, 357-362.
13. Bailey, D.G., Spence, J.D., Munoz, C. and Arnold, J.M.O. (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet. 337, 268-269.
14. Bakhiet, A.O. and Adam, S.E.I. (1995) Therapeutic utility, constituents and toxicity of some medicinal plants: A review. Vet. Human Toxicol. 37, 255-258.
15. Benninger, J., Schneider, H.T., Schuppan, D., Kirchner, T. and Hahn, E.G. (1999) Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology. 117, 1234-1237.
16. Bensky, D. and Gamble, A. (1986) Chinese Herbal Medicine-Materia Medica. Eastland Press, Seattle, WA.
17. Betz, J.M., Eppley, R.M., Taylor, W.C. and Andrzejewski, D. (1994) Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). J. Pharm. Sci. 83, 649-653.
18. Betz, J.M., White, K.D. and Der Marderosian, A.H. (1995) Gas chromatographic determination of yohimbine in commercial yohimbe products. J. A. O. A. C. Int. 78, 1189-1194.
19. Betz, J.M., Gay, M.L., Mossoba, M.M., Adams, S. and Portz, B.S. (1997) Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Má Huáng. J. A. O. A. C. Int. 80, 303-315.
20. Betz, J.M., Andrzejewski, D., Troy, A., Casey, R.E., Obermeyer, W.R., Page, S.W. and Woldemariam, T.Z. (1998) Gas chromatographic determination of toxic quinolizidine alkaloids in blue cohosh Caulophyllum thalictroides (L.) Michx. Phytochem. Anal. 9, 232-236.
21. Blackman, J.T., Maenpaa, J., Belle, D.J., Wrighton, S.A., Kivisto, K.T. and Neuvonen, P.J. (2000) Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin Pharmacol. Ther. 67, 382-390.
22. Blackwell, B. (1963) Hypertensive crisis due to monoamine-oxidase inhibitors. Lancet. 2, 849.
23. Bon, S., Hartmann, K. and Kuhn, M. (1999) Johanniskraut: Ein Enzyminduktor? Schweiz. Ap. Ztg. 16, 535-536.
24. Bosch, R., Friederich, U., Lutz, W.K., Brocker, E., Bachmann, M. and Schlatter, C. (1987) Investigations on DNA binding in rat liver and in Salmonella and on mutagenicity in the Ames test by emodin, a natural anthraquinone. Mutat. Res. 188, 161-168.
25. Bove, G.M. (1998) Acute neuropathy after exposure to sun in a patient treated with St. John's wort. Lancet. 352, 1121-1122.
26. Brusick, D. and Mengs, U. (1997) Assessment of the genotoxic risk from laxative senna products. Environ. Mol. Mutagen. 29, 1-9.
27. Buening, M.K., Chang, R.L., Huang, M.T., Fortner, J.G., Wood, A.W. and Conney, A.H. (1981) Activation and inhibition of benzo(a)pyrene and aflatoxin B1 meatbolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41, 67-72.
28. Burnham, B.E. (1995) Garlic as a possible risk for postoperative bleeding [comment]. Plast. Reconstr. Surg. 95, 213.
29. But, P.P. and Ma, S.C. (1999) Chinese herb nephropathy. Lancet. 354, 1731-1732.
30. By, A., Ethier, J.C., Lauriault, G., LeBelle, M., Lodge, B.A., Savard, C., Sy, W.-W. and Wilson, W.L. (1989) Traditional oriental medicines I. Black Pearl: identification and chromatographic determination of some undeclared medicinal ingredients. J. Chromatogr. 469, 406-411.
31. Cai, Y.N., Baerdubowska, W., Ashwoodsmith, M. and Digovanni, J. (1997) Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[A]pyrene and 7,12-dimethylbenz[A]anthracene in cultured mouse keratinocytes. Carcinogenesis. 18, 215.
32. Capwell, R.R. (1995) Ephedrine-induced mania from an herbal diet supplement. Am. J. Psychiatry. 152, 647.
33. Caraco, Y. (1998) Genetic determinants of drug responsiveness and drug interactions. Ther. Drug Monit. 20, 517.
34. Carson, S.W., Hill-Zabala, C.E., Roberts, S.H. and Hawke, R.L. (2000) Inhibitory effect of methanolic solution of St. John's wort (Hypericum perforatum) on cytochrome P450 3A4 activity in human liver microsomes. Clin. Pharmacol. Ther. 67, 99.
35. Catlin, D.H., Sekera, M. and Adelman, D.C. (1993) Erythroderma associated with ingestion of an herbal product. West. J. Med. 159, 491-493.
36. Chang, Y.L., Yao, Y.T., Wang, N.S. and Lee, Y.C. (1998) Segmental necrosis of small bronchi after prolonged intakes of Sauropus androgynus in Taiwan. Am. J. Respir. Crit. Care. Med. 157, 594-598.
37. Chevion, M. and Navok, T. (1983) A novel method for quantitation of favism-inducing agents in legumes. Anal. Biochem. 128, 152-158.
38. Clark, F. and Reed, R. (1992) Chaparral-induced toxic hepatitis-California and Texas, 1992. Morbidity and Mortality Weekly Reports. 41, 812-814.
39. Croom, Jr., E.M. and Walker, L. (1995) Botanicals in the pharmacy: New life for old remedies. Drug Topics. November 6, 84-93.
40. D'Arcy, P. (1993) Adverse reactions and interactions with herbal medicines, Part 2: Drug Interactions. Adverse Drug React. Toxicol. Rev. 12, 147.
41. Del Beccaro, M.A. (1995) Melaleuca oil poisoning in a 17-month-old. Vet. Hum. Toxicol. 37, 557-558.
42. Department of Health and Human Services. (1997a) Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements. Federal Register. 62, 5700-5709.
43. Department of Health and Human Services. (1997b) Dietary Supplements Containing Ephedrine Alkaloids; Proposed Rule. Federal Register. 62, 30678-30724.
44. Department of Health and Human Services. (1998) Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph. Federal Register. 63, 33592-33595.
45. De Smet, P.A.G.M. (1997) Yohimbe alkaloids-General discussion. In: De Smet, P.A.G.M., Keller, K., Hänsel, R. and Chandler, R.F. (eds.) Adverse Effects of Herbal Drugs 3. Springer-Verlag, Berlin, pp. 197-198.
46. De Smet, P.A.G.M. and D'Arcy, P.F. (1996) Drug interactions with herbals and other non-toxic remedies. In: D'Arcy, P.F., McElnay, J.C. and Welling, P.G. (eds.) Mechanisms of Drug Interactions. Springer-Verlag, Berlin.
47. De Smet, P.A.G.M. and Brouwers, J.R.B.J. (1997) Pharmacokinetic evaluation of herbal remedies: basic introduction, applicability, current status and regulatory needs. Clin. Pharmacokinet. 32, 427.
48. De Smet, P.A.G.M., Keller, K., Hänsel, R. and Chandler, R.F. (1992) Adverse Effects of Herbal Drugs 1, Springer-Verlag, Berlin.
49. De Smet, P.A.G.M., Keller, K., Hänsel, R. and Chandler, R.F. (1993) Adverse Effects of Herbal Drugs 2, Springer-Verlag, Berlin.
50. Der Marderosian, A.H. (1977) Medicinal teas-Boon or bane? Drug Ther. February, 178-184.
51. Der Marderosian, A.H. and Liberti, L. (1988) Natural Product Medicine. George F. Stickley Co., Philadelphia.
52. Demott, K. (1998) St. John's wort tied to serotonin syndrome. Clin. Psychiatry News. 26, 28.
53. D'Mello, J.P.F., Duffus, C.M. and Duffus, J.H. (eds.) (1991) Toxic Substances in Crop Plants. Royal Society of Chemistry, Cambridge, UK.
54. Downey, R.K. (1990) Canola: A quality brassica oilseed. In: Janick, J. and Simon, J.E. (eds.). Advances in New Crops. Proceedings of the First National Symposium NEW CROPS: Research, Development, Economics. Timber Press, Portland, OR, pp. 211-215.
55. Dubrovinskii, S.B. (1946) [About the alimentary toxicosis caused by heliotrope.] J. Sov. Prot. Health 6, 17-21 (in Russian). From: Environmental Health Criteria 80: Pyrrolizidine Alkaloids. World Health Organization, Geneva.
56. Eaton, E.A., Walle, U.K., Lewis, A.J., Hudson, T., Wilson, A.A. and Walle, T. (1996) Flavonoids, potent inhibitors of the human form phenolsulfotransferase: Potential role in drug metabolism and chemoprevention. Drug Metab. Dispos. 24, 232.
57. Edwards, D.J., Bellevue, III, F.H. and Woster, P.M. (1996) Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab. Dispos. 24, 1287-1290.
58. Ernst, E. (1999) Second thoughts about safety of St. John's wort. Lancet. 355, 2014-2016.
59. Fernald, M.L. (1987) Gray's Manual of Botany (8th edition), Dioscarides Press, Portland, OR.
60. Figeroa, P., Nembhard, O., Coleman, A. and Betton, M. (1992) Toxic hypoglycemic syndrome-Jamaica, 1989-1991. Morbidity and Mortality Weekly Reports. 41, 53-55.
61. Flom, M.S., Doskotch, R.W. and Beal, J.L. (1967) Isolation and characterization of alkaloids from Caulophyllum thalictroides. J. Pharm. Sci. 56, 1515-1517.
62. Formica, J.V. and Regelson, W. (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061-1080.
63. Francis, P.O. and Clarke, C.F. (1999) Angel trumpet lily poisoning in five adolescents: clinical findings and management. J. Paediatr. Child Health, 35, 93-95.
64. Frank, B.S., Michelson, W.B., Panter, K.E. and Gardner, D.R. (1995) Ingestion of poison hemlock (Conium maculatum). West. J. Med. 163, 573-574.
65. Fugh-Berman, A. (2000) Herb-drug interactions. Lancet. 355, 134-138.
66. Fuhr, U. (1998) Drug interactions with grapefruit juice: Extent, probable mechanism and clinical relevance. Drug Safety 18, 251.
67. Fuhr, U. and Kummert, A.L. (1995) The fate of naringin in humans: A key to grapefruit juicedrug interactions? Clin. Pharmacol. Ther. 58, 365-373.
68. Fuhr, U., Klittich, K. and Staib, A.H. (1993) Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br. J. Clin. Pharmacol. 35, 431-436.
69. Gajdusek, D.C. (1979) Recent observations on the use of kava in the New Hebrides. In: Efron, D.H., Holmstedt, B. and Kline, N.S. (eds.), Ethnopharmacologic Search for Psychoactive Drugs. Raven Press, New York, pp. 119-125.
70. Garner, L.F. and Klinger, J.D. (1985) Some visual effects caused by the beverage kava. J. Ethnopharmacol. 13, 307-311.
71. Ger, L.P., Chiang, A.A., Lai, R.S., Chen, S.M. and Tseng, C.J. (1997) Association of Sauropus androgynus and bronchiolitis obliterans syndrome: A hospital-based case-control study. Am. J. Epidemiol. 145, 842-849.
72. German, K., Kumar, U. and Blackford, H.N. (1995) Garlic and the risk of TURP bleeding. Br. J. Urol. 76, 518.
73. Gilbert, G.J. (1997) Ginkgo biloba [letter, comment]. Neurology. 48, 1137.
74. Goldman, J.A. and Myerson, G. (1991) Chinese herbal medicine: Camoflaged prescription antiinflammatory drugs, corticosteroids, and lead. Arthritis Rheum. 34, 1207.
75. Gordon, D.W., Rosenthal, G., Hart, J., Sirota, R. and Baker, A.L. (1995) Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications. JAMA. 273, 489-872.
76. Goth, A. (1974) Medical Pharmacology, 7th edition. C.V. Mosby Company, St. Louis, MO, p. 681.
77. Greene, G.S., Patterson, S.G. and Warner, E. (1996) Ingestion of angel's trumpet: An increasingly common source of toxicity. South. Med. J. 89, 365-369.
78. Grice, H.C., Becking, G. and Goodman, T. (1968) Toxic properties of nordihydroguaretic acid. Food Cosmet. Toxicol. 6, 155-161.
79. Grossman, E., Rosenthal, T., Peleg, E., Holmes, C. and Goldstein, D.S. (1993) Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J. Cardiovasc. Pharmacol. 22, 22-26.
80. Guengerich, F.P. and Kim, D.H. (1990) In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 11, 2275-2279.
81. Gurley, B.J., Gardner, S.F. and Hubbard, M.A. (2000) Content versus label claims in ephedracontaining dietary supplements. Am. J. Health-Syst. Pharm. 57, 963-969.
82. Ha, H.R., Chen, J., Leuenberger, P.M., Freiburghaus, A.U. and Follath, F. (1995) In vitro inhibition of midazolam and quinidine metabolism by flavonoids. Eur. J. Clin. Pharmacol. 48, 367.
83. Hamilton, R.J., Shih, R.D. and Hoffman, R.S. (1995) Mobitz Type I heart block after pokeweed ingestion. Vet. Human Toxicol. 37, 66-67.
84. Hartmeier, S.H. and Steurer, J. (1996) Mydriasis, Tachykardie. Schweiz. Rundsch. Med. Prax. 85, 495-498.
85. Heilpern, K.L. (1995) Zigadenus poisoning. Ann. Emerg. Med. 25, 259-262.
86. Hertog, M.G., Hollman, P.C., Katan, M.B. and Kromhout, D. (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer. 20, 21-29.
87. Hirono, L., Mori, H. and Haga, M. (1978) Carcinogenic activity of Symphytum officinale. J. Natl. Cancer Inst. 61, 865-869.
88. Hirono, L., Hagi, M., Fujii, M., Matsuura, S., Matsubara, N., Nakayama, M., Furuya, T., Hikichi, M., Takanashi, H., Uchida, E., Hosaka, S. and Ueno, I. (1979) Induction of hepatic tumors in rats by senkirkine and symphytine. J. Natl. Cancer Inst. 63, 469-472.
89. Hsiue, T.R., Guo, Y.L., Chen, K.W., Chen, C.W., Lee, C.H. and Chang, H.Y. (1998) Doseresponse relationship and irreversible obstructive ventilatory defect in patients with consumption of Sauropus androgynus. Chest. 113, 71-76.
90. Huang, K.C. (1993) The Pharmacology of Chinese Herbs. CRC Press, Boca Raton, FL.
91. Hutchens, A.R. (1992) A Handbook of Native American Herbs. Shambala Publications, Inc., Boston, MA.
92. Huxtable, R.J. (1990) The harmful potential of herbal and other plant products. Drug Safety. 5 (Suppl 1), 126-136.
93. Johne, A., Brockmoller, J., Bauer, S., Maurer, A., Langheinrich, M. and Roots, I. (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin. Pharmacol. Ther. 66, 338-345.
94. Jones, T.K. and Lawson, B.M. (1998) Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J. Pediatr. 132, 550-552.
95. Joseph, A.M., Biggs, T., Garr, M., Singh, J. and Lederle, F.A. (1991) Stealth steroids. N. Engl. J. Med. 324, 62.
96. Katz, M. and Saibil, F. (1990) Herbal hepatitis: Subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 12, 203-206.
97. Keeler, R.F. (1976) Lupin alkaloids from teratogenic and nonteratogenic lupins. III. Identification of anagyrine as a teratogen by feeding trials. J. Toxicol. Environ. Health. I, 887-898.
98. Kennelly, E.J., Flynn, T.J., Mazzola, E.P., Roach, J.A., McCloud, T.G., Danford, D.E. and Betz, J.M. (1999) Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture. J. Nat. Prod. 62, 1385-1389.
99. Khanin, M.N. (1948) [The etiology of toxic hepatitis with ascites.] Arch. Pathol. USSR. 1, 42-47 (in Russian). From: Environmental Health Criteria 80: Pyrrolizidine Alkaloids. World Health Organization, Geneva.
100. Kim, H.J., Chun, Y.J., Park, J.D., Kim, S.I., Roh, J.K. and Jeong, T.C. (1997) Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Medica. 63, 415.
101. Klintschar, M., Beham-Schmidt, C., Radner, H., Henning, G. and Roll, P. (1999) Forensic Sci. Int. 106, 191-200.
102. Klohs, M.W., Keller, F., Williams, R.E., Toekes, M.I. and Cronheim, G.E. (1959) A chemical and pharmacological investigation of Piper methysticum Forst. J. Med. Pharm. Chem. I, 95-103.
103. Koren, G., Randor, S., Martin, S. and Danneman, D. (1990) Maternal ginseng use associated with neonatal androgenization. JAMA. 264, 2466.
104. Kouzi, S.A., McMurtry, R.J. and Nelson, S.D. (1994) Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse. Chem. Res. Toxicol. 7, 850-856.
105. Kovarik, J.M., Rigaudy, L., Guerret, M., Gerbeau, C. and Rost, K.L. (1999) Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin. Clin. Pharmacol. Ther. 66, 391-400.
106. Krenzelok, E.P., Jacobsen, T.D. and Aronis, J.M. (1996) Poinsettia exposures have good outcomes... just as we thought. Am. J. Emerg. Med. 14, 671-674.
107. Krenzelok, E.P., Jacobsen, T.D. and Aronis, J.M. (1998) Is the yew really poisonous to yew? J. Toxicol. Clin. Toxicol. 36, 219-223.
108. Krishnamachari, K.A.V.R., Bhat, R.V., Krishnamurthi, D., Krishnaswamy, K. and Nagarajan, V. (1977) Aetiopathogenesis of endemic ascites in Surguja district of Madhya Pradesh. Ind. J. Med. Res. 65, 672-678.
109. Laliberté, L. and Villeneuve, J.P. (1996) Hepatitis after the use of germander, a herbal remedy. Can. Med. Assoc. J. 154, 1689-1692.
110. Langford, S.D. and Boor, P.J. (1996) Oleander toxicity: An examination of human and animal toxic exposures. Toxicology. 109, 1-13.
111. Lantz, M.S., Buchalter, E. and Giambanco, V. (1999) St. John's wort and antidepressant drug interactions in the elderly. J. Geriatr. Psychiatr. Neurol. 12, 7-10.
112. Larrey, D., Vial, T., Pauwels, A., Castot, A., Biour, M., David, M. and Michel, H. (1992) Hepatitis after germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann. Int. Med. 117, 129-132.
113. Lasker, J.M., Huang, M. and Conney, A.H. (1984) In vitro and in vivo oxidative drug metabolism by flavonoids. J. Pharmacol. Exp. Ther. 229, 162.
114. Lee, M.K., Cheng, B.W., Che, B.W. and Hsieh, D.P. (2000) Cytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparation. Toxicol. Sci. 56, 424-430.
115. Li, Y., Wang, E., Patten, C.J., Chen, L. and Yang, C.S. (1994) Effects of flavonoids on cytochrome P-450 dependent acetaminophen metabolism in rats and human microsomes. Drug Metab. Dispos. 22, 566-571.
116. Lin, T.J., Hsu, C.I., Lee, K.H., Shiu, L.L. and Deng, J.F. (1996) Two outbreaks of acute Tung Nut (Aleurites fordii) poisoning. J. Toxicol. Clin. Toxicol. 34, 87-92.
117. Liu, G. (1989) Pharmacological actions and clinical use of Fructus Shizandrae. Chin. Med. J. 102, 740.
118. Loeper, J., Descatoire, V., Letteron, P., Moulis, C., Degott, C., Dansette, P., Fau, D. and Pessayre, D. (1994) Hepatotoxicity of germander in mice. Gastroenterology. 106, 464-472.
119. Lord, G.M., Tagore, R., Cook, T., Gower, P. and Pusey, C.D. (1999) Nephropathy caused by Chinese herbs in the UK. Lancet. 354, 481-482.
120. Mabry, T.J., Hunziker, J.H. and DiFeo, Jr., D.R. (1977) Creosote Bush. Dowden, Hutchinson, and Ross, Stroudsburg, PA.
121. MacGregor, F.B., Abernathy, V.E., Dahabia, S., Cobden, I. and Hayes, P.C. (1989) Hepatotoxicity of herbal remedies. Br. Med. J. 299, 1156-1157.
122. Mai, I., Kruger, H., Budde, K., Johne, A., Brockmoller, J., Neumeyer, H.H., Roots, I. (2000) Hazardous pharmacokinetic interaction of St. John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin. Int. J. Clin. Pharmacol. Ther. 38, 500-502.
123. Markowitz, J.S., DeVane, C.L., Boulton, D.W., Carson, S.W., Nahas, Z. and Risch, S.C. (2000) Effect of St. John's wort (Hypericum perforatum) on Cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci. 66, 133-139.
124. Martinez, H.R., Bermudez, M.V., Rangel-Guerra, R.A. and de Leon Flores, L. (1998) Clinical diagnosis in Karwinskia humboldtiana polyneuropathy. J. Neurol. Sci. 154, 49-54.
125. McGuffin, M., Hobbs, C., Upton, R. and Goldberg, A. (1997) American Herbal Products Association's Botanical Safety Handbook. CRC Press, Boca Raton, FL.
126. McRae, S. (1996) Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can. Med. Assoc. J. 155, 293-295.
127. McTague, J.A. and Forney, R. (1994) Jamaican vomiting sickness in Toledo, Ohio. Ann. Emerg. Med. 23, 1116-1118.
128. Meda, H.A., Diallo, B., Buchet, J.P., Lison, D., Barennes, H., Ouangre, A., Sanou, M., Cousens, S., Tall, F. and Van de Perre, P. (1999) Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit. Lancet. 353, 536-540.
129. Merck Index. (2000) Guar Gum. 12th ed. on CD-ROM Version 12:3, Chapman & Hall/CRCnetBASE, Boca Raton, FL.
130. Miller, L.G. (1998) Herbal medicinals. selected clinical considerations focusing on known or potential drug-herb interactions. Arch. Intern. Med. 158, 2200-2211.
131. Mizugaki, M., Ito, K., Ohyama, Y., Konishi, Y., Tanaka, S. and Kurasawa, K. (1998) Quantitative analysis of aconitum alkaloids in the urine and serum of a male attempting suicide by oral intake of aconite extract. J. Anal. Toxicol. 22, 336-340.
132. Mossoba, M.M., Lin, H.S., Andrzejewski, D., Sphon, J.A., Betz, J.M., Miller, L.J., Eppley, R.M., Trucksess, M.W. and Page, S.W. (1994) Application of gas chromatography/matrix isolation/Fourier transform infrared spectroscopy to the identification of pyrrolizidine alkaloids from comfrey root (Symphytum officinale L.). J. A. O. A. C. Int. 77, 1167-1174.
133. Mostefa-Kara, N., Pauwels, A., Pines, E., Biour, M. and Levy, B.G. (1992) Fatal hepatitis after herbal tea. Lancet. 340, 674.
134. Mueller, S.O. and Stopper, H. (1999) Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim. Biophys. Acta. 1428, 406-414.
135. Nadir, A., Agrawal, S., King, P.D. and Marshall, J.B. (1996) Acute hepatitis associated with the use of a Chinese herbal product, Ma-Huang. Am. J. Gastroenterol. 91, 1436-1438.
136. Nagata, K.M. (1971) Hawaiian medicinal plants. Econ. Bot. 25, 245-254.
137. National Research Council. (1973) Toxicants Occurring Naturally in Foods. National Academy of Sciences, Washington, DC.
138. Nebel, A., Schneider, B.J., Baker, R.K. and Kroll, D.J. (1999) Potential metabolic interaction between St. John's wort and theophylline. Ann. Pharmacother. 33, 502.
139. Nielsen, S.E., Breinholt, V. and Justesen, U. (1998) In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica. 28, 389-401.
140. Nightingale, S.L. (1996) Warning issued about street drugs containing botanical sources of ephedrine. JAMA. 275, 1534.
141. Nortier, J.L., Martinez, M.C., Schmeiser, H.H., Arlt, V.M., Bieler, C.A., Petein, M., Depierreux, M.F., De Pauw, L., Abramowicz, D., Vereerstraeten, P. and Vanherweghem, J.L. (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N. Engl. J. Med. 342, 1686-1692.
142. Obermeier, M.T., White, R.E. and Yang, C.S. (1995) Effects of bioflavonoids on hepatic P450 activities. Xenobiotica. 25, 575.
143. Obermeyer, W.R., Musser, S.M., Betz, J.M., Casey, R.E., Pohland, A.E. and Page, S.W. (1995) Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc. Soc. Exp. Biol. Med. 208, 6-12.
144. Page, R.L. and Lawrence, J.D. (1999) Potentiation of warfarin by don quai. Pharmacotherapy. 19, 870-876.
145. Perrotta, D.M., Nickey, L.N., Raid, M., Caraccio, T., Mofenson, H.C., Waters, C., Morse, D., Osorio, A.M., Hoshiko, S. and Rutherford III, G.W. (1995) Jimson weed poisoning-Texas, New York, and California, 1994. Morbidity and Mortality Weekly Reports. 44, 41-44.
146. Perrotta, P.M., Coody, G. and Culmo, C. (1996) Adverse events associated with ephedrinecontaining products-Texas, December 1993-September 1995. Morbidity and Mortality Weekly Reports. 45, 689-693.
147. Phillipson, J.D. and Anderson, L.A. (1984) Herbal remedies used in sedative and antirheumatic preparations: Part 1. Pharm. J. 233, 80-82.
148. Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M. and Falloon, J. (2000) Marked reduction in indinavir exposure by St. John's wort. Lancet. 355, 547-548.
149. Pitz, W.J., Sosulski, F.W. and Hogge, L.R. (1980) Occurrence of vicine and convicine in seeds of some Vicia species and other pulses. Can. Inst. Food Sci. Technol. J. 13, 35-39.
150. Poulton, J.E. (1983) Cyanogenic compounds in plants and their toxic effects. In: Keeler, R.F. and Tu, A.T. (eds.), Handbook of Natural Toxins. Volume 1-Plant and Fungal Toxins. Marcel Dekker, Inc., New York, pp. 117-157.
151. Prakash, A.S., Pereira, T.N., Reilly, P.E. and Seawright, A.A. (1999) Pyrrolizidine alkaloids in human diet. Mutat. Res. 443, 53-67.
152. Raikhlin-Eisenkraft, B. and Bentur, Y. (2000) Ecbalium elaterium (squirting cucumber)-remedy or poison? J. Toxicol. Clin. Toxicol. 38, 305-308.
153. Rechcigl, Jr., M. (ed.) (1983) Handbook of Naturally Occurring Food Toxicants. CRC Press, Boca Raton, FL.
154. Ressler, C. (1962) Isolation and identification from common vetch of the neurotoxin β-cyano-L-alanine, a possible factor in neurolathyrism. J. Biol. Chem. 237, 733-735.
155. Ressler, C., Nigam, S.N. and Giza, Y.H. (1969) Toxic principle in vetch. Isolation and identification of γ-L-glutamyl-L-β-cyanoalanine from common vetch seeds. Distribution in some legumes. J. Am. Chem. Soc. 91, 2758-2764.
156. Ridker, P.M., Ohkuma, S., McDermott, W.V., Trey, C. and Huxtable, R.J. (1985) Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology. 88, 1050-1054.
157. Ries, C.A. and Sahud, M.A. (1975) Agranulocytosis caused by Chinese herbal medicines. Dangers of medications containing aminopyrine and phenylbutazone. JAMA. 231, 352-355.
158. Rizk, A.-F. M. (ed.) (1990) Poisonous Plant Contamination of Edible Plants. CRC Press, Boca Raton, FL.
159. Roby, C.A., Anderson, G.D., Kantor, E., Dryer, D.A. and Burstein, A.H. (2000) St. John's wort: effect on CYP3A4 activity. Clin. Pharmacol. Ther. 67, 451-457.
160. Roeder, E. (1995) Medicinal plants in Europe containing pyrrolizidine alkaloids. Pharmazie. 50, 83-98.
161. Rose, K.D., Croissant, P.D., Parliament, C.F. and Levin, M.B. (1990) Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic consumption: A case report. Neurosurgery. 26, 880-882.
162. Rosenblatt, M. and Mindel, J. (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N. Engl. J. Med. 336, 1108.
163. Routledge, P.A. and Spriggs, T.L.B. (1989) Atropine as possible contaminant of comfrey tea. Lancet. 1 (8644), 963-964.
164. Rowin, J. and Lewis, S.L. (1996) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion have also occurred. Neurology. 46, 1775-1776.
165. Ruschitzka, F., Meier, P.J., Turina, M., Luscher, T.F. and Noll, G. (2000) Acute heart transplant rejection due to Saint John's wort. Lancet. 355, 548-549.
166. Sandnes, D., Johansen, T., Teien, G. and Ulsaker, G. (1992) Mutagenicity of crude senna and senna glycosides in Salmonella typhimurium. Pharmacol. Toxicol. 71, 165-172.
167. Sarkar, M.A. (1995) Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes. Cancer Chemother. Pharmacol. 36, 448-450.
168. Scambia, G., Ranelletti, F.O., Panici, P.B., DeVincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M. and Mancuso, S. (1994) Quercetin potentiates the effect of adriamycin in a multidrug resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 34, 459-464.
169. Schneider, F., Lutin, P., Kintz, P., Astruc, D., Flesch, F. and Tempe, J.D. (1996) Plasma and urine concentrations of atropine after the ingestion of cooked deadly nightshade berries. J. Toxicol. Clin. Toxicol. 34, 113-117.
170. Schwartz, J. (1997) FDA proposes rules to curb risks from herbal stimulant. Washington Post. June 3, A02.
171. See, D., Gurnee, K. and LeClair, M. (1999) An in vitro screening study of 196 natural products for toxicity and efficacy. J.A.N.A. 2, 25-39.
172. Sheehan, D.M. (1998) Herbal medicines, phytoestrogens and toxicity: Risk:benefit considerations. Proc. Soc. Exp. Biol. Med. 217, 379-385.
173. Sheikh, N.M., Philen, R.M. and Love, L.A. (1997) Chaparral-associated hepatotoxicity. Arch Intern. Med. 157, 913-919.
174. Shi, J.Z. and Liu, G.T. (1996) Effect of alpha-hederin and sapindoside B on hepatic microsomal cytochrome P-450 in mice. Acta Pharmacologica Sinica. 17, 264.
175. Shulman, K.I. and Walker, S.E. (1999) Refining the MAOI diet: Tyramine content of pizzas and soy products. J. Clin. Psychiatry. 60, 191-193.
176. Sims, D.N., James, R. and Christensen, T. (1999) Another death due to Nicotiana glauca. J. Forensic Sci. 44, 447-449.
177. Slifman, N.R., Obermeyer, W.R., Aloi, B.K., Musser, S.M., Correll, W.A., Cichowicz, S.M., Betz, J.M. and Love, L.A. (1998) Contamination of botanical dietary supplements by Digitalis lanata. N. Engl. J. Med. 339, 806-811.
178. Smith, B.C. and Desmond, P.V. (1993) Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust. N. Z. J. Med. 23, 526.
179. Soller, R.W. (2000) Regulation in the herb market: The myth of the "unregulated industry." HerbalGram. 49, 64-68.
180. Sonda, L.P., Mazo, R. and Chancellor, M.B. (1990) The role of yohimbine for the treatment of erectile impotence. J. Sex Marital Ther. 16, 15-21.
181. Southgate, H.J., Egerton, M. and Dauncey, E.A. (2000) Lessons to be learned: A case study approach. Unseasonal severe poisoning of two adults by deadly nightshade (Atropa belladonna). J. R. Soc. Health. 120, 127-130.
182. Spiller, H.A., Willias, D.B., Gorman, S.E. and Sanftleban, J. (1996) Retrospective study of mistletoe ingestion. J. Toxicol. Clin. Toxicol. 34, 405-408.
183. Stillman, A.E., Huxtable, R.J., Fox, D.W., Hart, M.C., Bergeson, P.S., Counts, J.M., Cooper, L., Grunenfelder, G., Blackmon, J., Fretwell, M., Raey, J., Allard, J. and Bartleson, B. (1977) Poisoning associated with herbal teas-Arizona, Washington. Morbidity and Mortality Weekly Reports. 26, 257-259.
184. Sweeney, K., Gensheimer, K.F., Knowlton-Field, J. and Smith, R.A. (1994) Water hemlock poisoning-Maine, 1992. Morbidity and Mortality Weekly Reports. 43, 229-231.
185. Swenson, J. (1996) Man convicted of driving under influence of kava. Deseret News, Salt Lake City, UT, 5 August.
186. Tandon, R.K., Tandon, B.N., Tandon, H.D., Bhatia, M.L., Bhargava, S., Lal, P. and Arora, R.R. (1976a) Study of an epidemic of veno-occlusive disease in India. Gut. 17, 849-855.
187. Tandon, B.N., Tandon, H.D., Tandon, R.K., Narendranathan, M. and Joshi, Y.K. (1976b) Epidemic of veno-occlusive disease in central India. Lancet. 2, 271-272.
188. Tandon, H.D., Tandon, B.N., Tandon, R.K. and Nayak, N.C. (1977) A pathological study of the liver in an epidemic outbreak of veno-occlusive disease. Ind. J. Med. Res. 65, 679-684.
189. Tandon, B.N., Tandon, H.D. and Mattocks, A.R. (1978a) An epidemic of veno-occlusive disease of the liver in Afghanistan. Am. J. Gastroenterol. 70, 607-613.
190. Tandon, B.N., Tandon, H.D. and Mattocks, A.R. (1978b) Study of an epidemic of venoocclusive disease in Afghanistan. Ind. J. Med. Res. 68, 84-90.
191. Tate, M.E. and Enneking, D. (1992) A mess of red pottage. Nature. 359, 357-358.
192. Thatte, U. and Dahanukar, S. (1999) The Mexican poppy poisons the Indian mustard: Facts and figures. J. Assoc. Physicians India. 47, 332-335.
193. Thummel, K.E. and Wilkinson, G.R. (1998) In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 38, 389-430.
194. Tibballs, J. (1995) Clinical effects and management of eucalyptus oil ingestion in infants and young children. Med. J. Aust. 163, 177-180.
195. Tiongson, J. and Salen, P. (1998) Mass Ingestion of Jimson Weed by eleven teenagers. Del. Med. J. 70, 471-476.
196. Toubro, S., Astrup, A.V., Breum, L. and Quaade, F. (1993) Safety and Efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture. Int. J. Obes. Relat. Metab. Disord. 17, S69-S72.
197. Treasure, J. (2000) Herbal pharmacokinetics: A practitioner update with reference to St. John's wort (Hypericum perforatum) interactions. J. Am. Herbal. Guild. 1, 2-11.
198. Tsyrlov, I.B., Mikhailenko, V.M. and Gelboin, H.V. (1994) Isozyme-and species-specific susceptibility of cDNA-expressed CYP1A P-450s to different flavonoids. Biochimica et Biophysica Acta. 1205, 325-335.
199. Tyler, V.E. (1993) The Honest Herbal. Pharmaceutical Products Press, New York, NY.
200. United States Code, Title 21. (2000) Federal Food, Drug, and Cosmetic Act of June 25, 1938, As Amended, sec. 201 (g)(1)(B).
201. United States Pharmacopeial Convention. (1999) The United States Pharmacopeia 24, The National Formulary 19. United States Pharmacopeial Convention, Inc., Rockville, MD, pp. 642-645, 1318-1322, 1439-1441.
202. United States Public Law 103-417. 103rd Cong., 25 October 1994. Dietary Supplement Health and Education Act of 1994.
203. Vale, S. (1998) Subarachnoid haemorrhage associated with ginkgo biloba. Lancet. 352, 36.
204. Vanhaelen, M., Vanhaelen-Fastre, R., But, P. and Vanherweghem, J.L. (1994) Identification of aristolochic acid in Chinese herbs. Lancet. 343, 174.
205. Vanherweghem, J.L., Depierreux, M., Tielemans, C., Abramowicz, D., Dratwa, M., Jadoul, M., Richard, C., Vandervelde, D., Verbeelen, D., Vanhaelen-Fastre, R. and Vanhaelen, M. (1993) Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet. 341, 387-391.
206. Vollmer, J.J., Steiner, N.C., Larsen, G.Y., Muiehead, K.M. and Molyneux, R.J. (1987) Pyrrolizidine alkaloids: Testing for toxic constituents of comfrey. J. Chem. Ed. 64, 1027-1030.
207. Von Moltke, L.L., Greenblatt, D.J., Schmider, J., Wright, C.E., Harmatz, J.S. and Shader, R.I. (1998) In vitro approaches to predicting drug interactions in vivo. Biochem. Pharmacol. 55, 113-122.
208. Walgren, R.A., Walle, U.K. and Walle, T. (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55, 1721-1727.
209. Walter-Sack, I. and Klotz, U. (1996) Influence of diet and nutritional status on drug metabolism. Clin. Pharmacokinet. 31, 41-64.
210. Watson, D.H. (ed.) (1987) Natural Toxicants in Food: Progress and Prospects. VCH Publishers, New York, NY.
211. Weiner, M.A. (1971) Ethnomedicine in Tonga. Econ. Bot. 25, 423-450.
212. Westendorf, J. (1993) Anthranoid derivatives-general discussion. In: De Smet, P.A.G.M., Keller, K., Hänsel, R. and Chandler, R.F. (eds.), Adverse Effects of Herbal Drugs 2, Springer-Verlag, Berlin, pp. 105-108.
213. Weston, C.F.M., Cooper, B.T., Davies, J.D. and Levine, D.F. (1987) Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br. Med. J. 295, 183.
214. Willey, L.B., Mady, S.P., Cobaugh, D.J. and Wax, P.M. (1995) Valerian overdose: A case report. Vet. Hum. Toxicol. 37, 364-365.
215. Wilson, M. (2000) Driver busted for kava tea-San Mateo County case first of its kind in state. San Francisco Chronicle, San Francisco, CA, 29 April.
216. Woldemariam, T.Z., Betz, J.M. and Houghton, P.J. (1997) Analysis of aporphine and quinolizidine alkaloids from Caulophyllum thalictroides by densitometry and HPLC. J. Pharm. Biomed. Anal. 15, 839-843.
217. Wu, C.L., Hsu, W.H., Chiang, C.D., Kao, C.H., Hung, D.Z., King, S.L. and Deng, J.F. (1997) Lung injury related to consuming Sauropus androgynus vegetable. J. Toxicol. Clin. Toxicol. 35, 241-248.
218. Yang, C.S., Lin, C.H., Chang, S.H. and Hsu, H.C. (2000) Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am. J. Kidney Dis. 35, 313-318.
219. Yates, K.M., O'Connor, A. and Horsely, C.A. (2000) "Herbal Ecstasy": A case series of adverse reactions. N. Z. Med. J. 113, 315-317.
220. Yue, Q.-Y., Bergquist, C., Gerdén, B. (2000) Seven cases of decreased effect of warfarin during concomitant treatment with St. John's wort. Lancet. 355, 577.
221. Zhang, Y.P., Sussman, N., Macina, O.T., Rosenkranz, H.S. and Klopman, G. (1996) Prediction of the carcinogenicity of a second group of organic chemicals undergoing carcinogenicity testing. Environ. Health Perspect. 104, 1045-1050.